Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New antifungal agents from Lilly

March 10, 1997

Abelcet receives additional European approval

March 6, 1997

Antisense-based drug highly effective for eradicating RSV

March 6, 1997

Advisory committee to review supplemental NDA for Maxipime

March 4, 1997

ViroPharma's antiviral candidate enters pediatric clinical trials

March 4, 1997

Cephalosporin antibiotics revealed by Microcide

March 4, 1997

BioChem Pharma and Oncogene Science expand collaboration

March 3, 1997

Tokyo Tanabe claims antifungal agents

March 3, 1997

Amphotec now approved in 20 countries

Feb. 28, 1997

Pfizer's new antifungal agents

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.